£V3PM
Dit fonds streeft ernaar de FTSE Developed Asia Pacific All Cap Choice Index te volgen, die grote, middelgrote en kleine op ESG-criteria gescreende aandelen omvat uit ontwikkelde markten in de regio Azië-Pacific, waaronder Japan.
Naam | Gewicht | Marktkapitalisatie | Prijs | Dagwijziging |
|---|---|---|---|---|
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
Greatland Resources £GGPMaterialen | 0,04% | - | ||
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
Telix Pharmaceutical $TLXGezondheid | 0,03% | - | ||
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A |